Tetraphenylporphyrin within Polyvinylpyrrolidone matrix (TPP-PVP)

Tetraphenylporphyrin (TPP) within a Polyvinylpyrrolidone (PVP) matrix is a composite material utilized as a photosensitizer delivery system for photodynamic therapy (PDT) (PubChem CID 6148, 6917). TPP is a synthetic porphyrin that exhibits strong light absorption and high singlet oxygen quantum yields, but its clinical utility is often limited by its hydrophobic nature and tendency to aggregate in aqueous environments. The PVP matrix acts as a biocompatible, water-soluble carrier that stabilizes TPP, preventing aggregation and enhancing its bioavailability and therapeutic efficacy (Journal of Photochemistry and Photobiology B: Biology, 2015). When irradiated with light of a specific wavelength, the TPP molecules undergo electronic excitation and transfer energy to molecular oxygen, producing highly reactive singlet oxygen. This process results in localized oxidative stress and subsequent cell death, making it effective for treating certain cancers and microbial infections (National Cancer Institute, PDT Overview). As a drug-excipient formulation, TPP-PVP is a therapeutic agent rather than a biological target such as a receptor or enzyme.

Other names

meso-Tetraphenylporphyrin in PVPTPP/PVP compositeTPP-PVP formulation5,10,15,20-Tetraphenyl-21H,23H-porphine in PVP

Type II photodynamic mechanism involving energy transfer from the excited triplet state of the porphyrin to ground-state molecular oxygen, generating cytotoxic singlet oxygen (PubChem CID 6148).